This page is updated frequently with new Peritoneal-related patent applications.
| Tunneling guidewire|
A medical device tunneling system, and a method of using the same, to subcutaneously route trocars, also commonly referred to as tunnelers, or introducers, having a cannula, stylet, and a guidewire stylet, inside a patient during a surgical procedure, such as a ventriculoperitoneal hydrocephalus shunt implantation, from a proximal entry point to a distal end point, in order to subcutaneously route and implant a medical device, such as shunt tubing, in a patient.. .
Arkis Biosciences Inc.
|Pneumatic intermittently rigidifying an endoscopic specimen retaining carrier|
An insufflation/desufflation apparatus/system, and method of use thereof. An airtight tube is secured circumferentially to the opening of an endoscopic containment bag.
University Of South Florida
|System and treating prolapse and incontinence|
A system and method of treating vaginal prolapse and incontinence comprises a kit. The kit includes a mesh graft configured for attachment to the anterior and posterior vaginal walls to thereby treat the vaginal prolapse.
Boston Scientific Scimed, Inc.
A model for practicing transabdominal pre-peritoneal (tapp) and total extraperitoneal (tep) approaches for laparoscopic hernia repairs is provided. The model simulates an insufflated space between the abdominal muscles and peritoneum.
Applied Medical Resources Corporation
|Universal portable artificial kidney for hemodialysis and peritoneal dialysis|
Methods, systems, and kits are provided for performing hemodialysis, hemodiafiltration, and peritoneal dialysis on a portable machine suitable for both clinical and home use. Peritoneal dialysate can be flowed into and out of the peritoneal cavity, and can also be regenerated within the system, without the need for introducing fresh dialysate.
Fresenius Medical Care Holdings, Inc.
|Gastric, cutaneous, or peritoneal delivery of frozen mist to induce therapeutic hyperthermia|
peritoneal heat exchange provides the benefit of extremely rapid cooling of the patient's target organs such as the heart and brain as well as facilitating global patient body temperature reduction to therapeutically effective temperatures. The heat exchange medium of the present invention is a chilled gaseous fluid suspension of frozen ice particles..
Qool Therapeutics, Inc.
|Compositions and methods for treating ovarian cancer including preventing the recurrence thereof|
A method of treating ovarian cancer (oc) includes administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising vicrostatin and/or a protein substantially similar to vicrostatin. The administration is preferably performed intraperitoneally.
University Of Southern California
|Method and use of draining fluid above the cribriform plate|
Alzheimer's disease is a neurological disorder marked by progressive memory and cognitive impairments that eventually result in death. Currently, there are no effective therapies or cures that slow or halt the relentless progression of alzheimer's disease.
|Electromyography with prosthetic or orthotic devices|
Systems, devices and methods for control of a prosthetic or orthotic device (pod) based on electromyography (emg) signals are described. The pod may be a lower or upper limb pod having one or more joints.
Össur Iceland Ehf
|Ventriculoperitoneal shunt with distal balloon|
A ventriculoperitoneal shunt has a ventricular catheter and a peritoneal catheter, with a shunt valve connected in line between the catheters to define a drainage patch for cerebrospinal fluid from the brain ventricle to the peritoneal cavity. An inflatable balloon on the peritoneal catheter precludes migration or displacement of the catheter in the peritoneal cavity, thereby eliminating or minimizing corrective revision surgery..
University Of Iowa Research Foundation
Support for holding the external device of a peritoneal dialysis catheter, and additional system for attaching the support
The invention relates to a support (1) comprising a u-shaped enveloping body (1) having an elastic structure formed by a front limb (1a), a rear limb (1b) and a concave bottom (1c), where the u-shaped enveloping body (1) defines an inner space (9) where the external device (3) of the catheter fits tightly. The support (1) also has at least one extension (4) which projects from one of the limbs of the u-shaped enveloping body (1), where said limb and the extension (4) face each other, forming a clip device (5) for attaching the support to the patient's garment, the clip device (5) being formed outside the inner space (9) of the u-shaped enveloping body (1)..
Medical treatment system and methods using a plurality of fluid lines
A medical treatment system, such as peritoneal dialysis system, may include control and other features to enhance patient comfort and ease of use. For example, a peritoneal dialysis system may include patient line state detector for detecting whether a patient line is primed before it is to be connected to the patient.
Deka Products Limited Partnership
Flexible tubing occlusion assembly
Described herein are the occlusion assemblies configured to facilitate the opening and closing by occlusion of flexible tubing. In particular embodiments, the occlusion assemblies are associated with or form part of a medical infusion device, such as a hemodialysis device, peritoneal dialysis device, plasmapheresis device, etc., and may be controllably and automatically operated to facilitate fluid handling by such devices.
Deka Products Limited Partnership
Automated peritoneal dialysis system using a peristaltic pump and non-contact sensors
An automated peritoneal dialysis therapy device includes pump tubing for delivering dialysate to a patient and for removing waste from the patient; a retractable peristaltic pump assembly; and a processor for controlling operations of the automated peritoneal dialysis therapy device. The retractable peristaltic pump assembly includes a retractable peristaltic pump having a pump rotor and a pump base, a heating source, located in the pump base, to heat the dialysate, a first temperature sensor to measure a temperature of the heating source, a second temperature sensor to measure a temperature of the dialysate, a flow sensor to measure an amount of dialysate being pumped, a pressure sensor to measure a pressure of the dialysate being pumped, and a motor to rotate the pump rotor.
Peritoneal peeling surgical instrument
The present invention has been made with the aim to provide a surgical instrument, which can be put into a space between a peritoneum and muscle via a tunnel formed at the peritoneum easily and can be pulled strongly in a direction to peel the peritoneum from the muscle in hernia repair surgery or the like. A peritoneal peeling surgical instrument, which is put between muscle and a peritoneum via a tunnel formed at the peritoneum to peel the peritoneum from the muscle, includes: an operation part to be grasped and operated by the user; a shaft part connected with the operation part; a hinge part disposed at the tip of the shaft part; and a hook part connected with the shaft part via the hinge part.
Japanese Organization For Medical Device Development, Inc.
Modulation of timp1 and timp2 expression
Provided herein are compositions, methods and kits for modulating expression of target genes, particularly of tissue inhibitor of metalloproteinase 1 and of tissue inhibitor of metalloproteinase 2 (timp1 and timp2, respectively). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (sina), short interfering rna (sirna), double-stranded rna (dsrna), micro-rna (mirna) or short hairpin rna (shrna)) that modulate a gene encoding timp1 and timp2, for example, the gene encoding human timp1 and timp2.
Nitto Denko Corporation
Anti-wt1/hla bi-specific antibody
Disclosed herein is a bi-specific form of a t cell receptor mimic (tcrm) mab with reactivity to human immune effector cell antigen and a wt1 peptide/hla-a epitope. This antibody selectively bound to leukemias and solid tumor cells expressing wt1 and hla-a as well as activated resting human t cells to release interferon-(ifn-γ) and to kill the target cancer cells in vitro.
Eureka Therapeutics, Inc.
Device with a fluid pump, at least two points of access to the abdominal wall and tubes connecting the fluid pump and abdominal wall
A device with a blood pump, at least two points of access to the abdominal wall and tubes connecting the blood pump and points of access to the abdominal wall, which is known as a peritoneal dialysis system, is equipped with a co2 removal arrangement, in order to use it tor blood oxygenation and/or co2 removal.. .
Novel compounds as rearranged during transfection (ret) inhibitors
This invention relates to novel compounds which are inhibitors of the rearranged during transfection (ret) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of gastrointestinal sensitivity, motility and/or secretion and/or abdominal disorders or diseases and/or treatment related to diseases related to ret dysfunction or where modulation of ret activity may have therapeutic benefit including but not limited to all classifications of irritable bowel syndrome (ibs) including diarrhea-predominant, constipation-predominant or alternating stool pattern, functional bloating, functional constipation, functional diarrhea, unspecified functional bowel disorder, functional abdominal pain syndrome, chronic idiopathic constipation, functional esophageal disorders, functional gastroduodenal disorders, functional anorectal pain, inflammatory bowel disease, proliferative diseases such as non-small cell lung cancer, hepatocellular carcinoma, colorectal cancer, medullary thyroid cancer, follicular thyroid cancer, anaplastic thyroid cancer, papillary thyroid cancer, brain tumors, peritoneal cavity cancer, solid tumors, other lung cancer, head and neck cancer, gliomas, neuroblastomas, von hippel-lindau syndrome and kidney tumors, breast cancer, fallopian tube cancer, ovarian cancer, transitional cell cancer, prostate cancer, cancer of the esophagus and gastroesophageal junction, biliary cancer, adenocarcinoma, and any malignancy with increased ret kinase activity.. .
Glaxosmithkline Intellectual Property Development Limited
Substrate having an electron donating surface with metal particles comprising palladium on said surface
There is disclosed a substrate with an electron donating surface, characterized in having metal particles on said surface, said metal particles comprising palladium and at least one metal selected from the group consisting of gold, ruthenium, rhodium, osmium, iridium, and platinum, wherein the amount of said metal particles is from about 0.001 to about 8 μg/cm2. Examples of coated objects include contact lenses, pacemakers, pacemaker electrodes, stents, dental implants, rupture nets, rupture mesh, blood centrifuge equipment, surgical instruments, gloves, blood bags, artificial heart valves, central venous catheters, peripheral venous catheters, vascular ports, haemodialysis equipment, peritoneal dialysis equipment, plasmapheresis devices, inhalation drug delivery devices, vascular grafts, arterial grafts, cardiac assist devices, wound dressings, intermittent catheters, ecg electrodes, peripheral stents, bone replacing implants, orthopaedic implants, orthopaedic devices, tissue replacing implants, intraocular lenses, sutures, needles, drug delivery devices, endotracheal tubes, shunts, drains, suction devices, hearing aid devices, urethral medical devices, and artificial blood vessels..
Preventing or mitigating chemotherapy induced alopecia using vitamin d
The invention provides methods and pharmaceutical compositions for preventing or mitigating chemotherapy-induced alopecia (cia). The pharmaceutical compositions of the invention comprise an effective amount of a vitamin d compound in a topical formulation.
Isoxazole compound for the treatment of cancer
The use of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide or a tautomer thereof or a pharmaceutically acceptable salt or a hydrate or a solvate for the treatment of cancer of the bladder, the colon, the liver, the lung, the breast, the vagina, the ovaries, the pancreas, the kidney, the stomach, the gastrointestinal tract, the prostate, the head and neck, the peritoneal cavity, the thyroid, the bone, the brain, the central nervous system and/or the blood and/or for the treatment of myelodysplastic syndrome, systemic mastocytosis, von hippel-lindau syndrome, multicentric castleman disease and/or psioriasis.. .
Sensor system for detection of phases and/or phase transitions in peritoneal dialysis treatments
The invention is directed to a sensor system of a medial system, in particular a manually operable, gravimetric system for continuous ambulant peritoneal dialysis (capd) for detection of a treatment status, in particular for detection of a phase segment and/or a phase transition in peritoneal dialysis.. .
Fresenius Medical Care Deutschland Gmbh
Dry peritoneal dialysis concentrate system
A dry peritoneal dialysis (pd) concentrate system may be used in connection with a pd cycler. The dry pd concentrate system includes a concentrate container with at least two concentrate compartments, and at least one of the compartments contains a dry pd concentrate component.
Fresenius Medical Care Deutschland Gmbh
Laparoscopic surgery solution and using the same
The present invention provides a laparoscopic surgery method comprising inspection of peritoneal surfaces under an isotonic solution comprising a contrast enhancing agent using near contact scanning by a laparoscope. Accordingly, the method according to the current invention comprises introducing the solution and the contrast enhancing agent into the retroperitoneal space through a catheter or a channel of a laparoscope using an irrigation pump.
Mesothelin vaccines and model systems
Mesothelin can be used as an immunotherapeutic target. It induces a cytolytic t cell response.
The Johns Hopkins University
Treatment of peritoneal injury using jak inhibitors
The invention provides, in certain embodiments, a method of preventing and/or treating peritoneal injury and/or diminished function by administering an effective amount of one or more inhibitors of jak. The invention also provides a pharmaceutical composition including a jak inhibitor for the treatment of peritoneal injury and/or diminished function.
Los Angeles Biomedical Research Institute At Harbor-ucla Medical Center
Surgical access system and related methods
A surgical access system including a tissue distraction assembly and a tissue retraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site. Some embodiments of the surgical access system may be particularly suited for establishing an operative corridor to a surgical target site in the spine.
Partially absorbable fiber-reinforced composites for controlled drug delivery
This invention describes a partially absorbable, fiber-reinforced composite in the form of a ring, or a suture-like thread, with modified terminals for use as a controlled delivery system of at least one bioactive agent, wherein said composite comprising an absorbable fiber construct capable of providing time-dependent mechanical properties of a biostable elastomeric matrix containing an absorbable microparticulate ion-exchanger to modulate the release of the bioactive agent(s) for a desired period(s) of time at a specific biological site; this can be a vaginal canal, peritoneal cavity, scrotum, prostate gland, an ear loop or subcutaneous tissue. Such drug delivery systems can be used for the local administration of at least one bioactive agent, including those used as contraceptive, antimicrobial, anti-inflammatory and/or antiviral agents as well as for cancer treatment..
Method and system for producing and delivering airless medical ice slurry to induce hypothemia
The present invention relates to a method and system for producing and delivering sterile, airless, and highly loaded ice slurry for inducing therapeutic hypothermia. The method is capable of producing and delivering ice slurry in a patient to induce hypothermia through internal and external cooling methods such as subcutaneous, intravascular, intraperitoneal, gastrointestinal, and lung methods.
Wireless Communication Device
Follow us on Twitter
This listing is a sample listing of patent applications related to Peritoneal for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Peritoneal with additional patents listed. Browse our RSS directory or Search for other possible listings.